Novo Nordisk, Merck, GSK to Refund 340B Covered Entities for Overcharges

Novo Nordisk, Merck and GSK announced they will refund covered entities following certain overcharges for 340B drugs.
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Battlefront Shifts from Contract Pharmacies to Rebates

Ted Slafsky, publisher and CEO of 340B Report, writes on drugmaker efforts to convert upfront 340B discounts to a rebate model.
By the first week of June, we should have a better sense of how the Trump administration plans to address [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from CaptureRx

img
img

TIP: Use quarterly eRx data analysis to identify contract pharmacy expansion opportunities, including independent pharmacies.


Every quarter,

Read More »

News Alert

Oregon Senate Narrowly Passes 340B Contract Pharmacy Access Bill

The Oregon Senate recently passed an amended 340B contract pharmacy access bill.
Oregon state senators late yesterday narrowly passed legislation to prohibit drugmakers from restricting 340B contract pharmacy access in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House GOP Lawmaker Spartz Introduces Bill That 340B Provider Advocates Say Would Drive Them Out of the Program and Potentially Force Closures

U.S. Rep. Victoria Spartz (R-Ind.) introduced the legislation (H.R. 3222), known as the “Stopping Medicare Abuses to Restore Trust in Health Care Act” or SMART Health Care Act, on May 6. 340B provider advocates strongly oppose the bill's 340B provisions.
An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Don’t Overlook the Importance of an HIN on Your Wholesale Accounts

SPONSORED CONTENT

It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is

Read More »

Vermont House Modifies 340B Contract Pharmacy Access and Hospital Reporting Bill, Hospital Advocates Voice Concerns About Changes

Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Oregon, Illinois State Senators Push for Amendments to 340B Contract Pharmacy Access Bills

Oregon state senators have proposed competing amendments to a 340B contract pharmacy access bill that passed the state House.
Oregon state senators are pushing for competing amendments to a 340B contract pharmacy access bill that passed the state House; [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Files New Lawsuits to Block 340B Contract Pharmacy Access Laws in Tennessee, Utah

AstraZeneca sued to block Utah's 340B contract pharmacy access law one day after PhRMA challenged Tennessee's similar statute.
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live